KORU Medical Systems (NASDAQ:KRMD) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS

KORU Medical Systems (NASDAQ:KRMD) released its quarterly earnings results on Wednesday. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02, Zacks reports. KORU Medical Systems had a negative net margin of 48.18% and a negative return on equity of 27.82%. The company had revenue of $8.20 million for the quarter, compared to the consensus estimate of $7.49 million. During the same quarter in the prior year, the firm earned ($0.05) earnings per share.

KORU Medical Systems Trading Up 5.8 %

Shares of NASDAQ KRMD traded up $0.13 during midday trading on Thursday, hitting $2.38. The company’s stock had a trading volume of 90,707 shares, compared to its average volume of 96,461. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $4.30. The company has a current ratio of 4.55, a quick ratio of 3.77 and a debt-to-equity ratio of 0.02. The firm has a market cap of $108.79 million, a P/E ratio of -8.21 and a beta of 0.56. The business’s 50 day moving average is $2.19 and its two-hundred day moving average is $2.24.

Analyst Upgrades and Downgrades

Separately, B. Riley reaffirmed a “buy” rating and issued a $4.00 price target on shares of KORU Medical Systems in a report on Thursday, March 14th.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.